Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stem cell technologies in regenerative medicine.

Kewal K Jain1

  • 1Jain PharmaBiotech, Blaesiring 7, CH-4057 Basel, Switzerland. jain@pharmabiotech.ch

Expert Opinion on Biological Therapy
|October 22, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Personalized Immuno-Oncology.

Medical principles and practice : international journal of the Kuwait University, Health Science Centre·2020
Same author

An Overview of Drug Delivery Systems.

Methods in molecular biology (Clifton, N.J.)·2019
Same author

Role of Nanobiotechnology in Drug Delivery.

Methods in molecular biology (Clifton, N.J.)·2019
Same author

A Critical Overview of Targeted Therapies for Glioblastoma.

Frontiers in oncology·2018
Same author

Personalized neurology.

Personalized medicine·2018
Same author

Personalized Management of Cardiovascular Disorders.

Medical principles and practice : international journal of the Kuwait University, Health Science Centre·2017

The IIR Life Sciences conference explored stem cell technologies for regenerative medicine, including ethical and financial considerations of embryonic stem (ES) cell therapy. Experts discussed advancements and challenges in this rapidly evolving field.

Area of Science:

  • Regenerative Medicine
  • Stem Cell Technology
  • Biotechnology

Background:

  • The IIR Life Sciences conference convened in London on July 11-12, 2002, focusing on stem cell technologies within regenerative medicine.
  • The agenda encompassed technological, ethical, regulatory, and financial dimensions of embryonic stem (ES) cell therapy.
  • Prof. William Kridel provided an introductory overview of embryonic stem cells.

Framework:

  • The conference addressed the practical application of stem cell technologies.
  • Discussions included the ethical and regulatory landscape governing ES cell research and therapy.
  • Financial aspects critical for the advancement of regenerative medicine were also a key focus.

Implementation:

  • Selected presentations highlighted key advancements and challenges in stem cell applications.

Related Experiment Videos

  • The event served as a platform for knowledge exchange among researchers and industry professionals.
  • While basic technologies were not detailed, the focus remained on their application in therapy.

    • Implications:

    • The conference underscored the multidisciplinary nature of regenerative medicine, integrating science, ethics, and finance.
    • Findings suggest a growing momentum in the field of ES cell therapy.
    • The event highlighted the need for continued dialogue on ethical and regulatory frameworks to support therapeutic development.